<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 28.4: Advanced Renal and Hepatic Disease Nutrition | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

.meta-badge .icon {
 font-size: 14px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

.welcome-box p {
 margin: 0;
 font-size: 16px;
 color: #44403c;
 line-height: 1.7;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li:last-child {
 border-bottom: none;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

ul, ol {
 margin: 20px 0;
 padding-left: 24px;
}

li {
 font-size: 16px;
 line-height: 1.7;
 color: #374151;
 margin-bottom: 10px;
}

li strong {
 color: #722F37;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-header .subtitle {
 color: rgba(255, 255, 255, 0.8);
 font-size: 14px;
 margin: 4px 0 0 0;
}

.case-study-content {
 padding: 28px;
}

.patient-profile {
 display: flex;
 align-items: center;
 gap: 16px;
 padding: 16px;
 background: #f9fafb;
 border-radius: 12px;
 margin-bottom: 20px;
}

.patient-avatar {
 width: 56px;
 height: 56px;
 background: linear-gradient(135deg, #fecaca, #fca5a5);
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 28px;
 flex-shrink: 0;
}

.patient-info h4 {
 margin: 0;
 color: #722F37;
 font-size: 16px;
 font-weight: 700;
}

.patient-info p {
 margin: 4px 0 0 0;
 font-size: 14px;
 color: #6b7280;
}

/* COMPARISON GRID */
.comparison-grid {
 display: grid;
 grid-template-columns: repeat(2, 1fr);
 gap: 20px;
 margin: 32px 0;
}

.comparison-card {
 background: white;
 padding: 28px;
 border-radius: 16px;
 border: 2px solid #e5e7eb;
 transition: transform 0.2s, box-shadow 0.2s;
}

.comparison-card:hover {
 transform: translateY(-4px);
 box-shadow: 0 12px 24px rgba(0, 0, 0, 0.1);
}

.comparison-card.conventional {
 border-top: 4px solid #ef4444;
}

.comparison-card.functional {
 border-top: 4px solid #22c55e;
}

.card-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-weight: 700;
 margin-bottom: 12px;
 display: block;
}

.conventional .card-label {
 color: #dc2626;
}

.functional .card-label {
 color: #16a34a;
}

.card-text {
 font-size: 18px;
 font-style: italic;
 line-height: 1.5;
 color: #1f2937;
 margin: 0;
}

/* CONTENT LIST */
.content-list {
 list-style: none;
 padding: 0;
 margin: 24px 0;
}

.content-list li {
 padding: 12px 0 12px 36px;
 position: relative;
 font-size: 16px;
 color: #374151;
 border-bottom: 1px solid #f3f4f6;
}

.content-list li:last-child {
 border-bottom: none;
}

.content-list li::before {
 content: '‚Üí';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
 font-size: 18px;
}

.content-list li strong {
 color: #722F37;
}

/* PRINCIPLE CARDS */
.principles-grid {
 display: flex;
 flex-direction: column;
 gap: 16px;
 margin: 32px 0;
}

.principle-card {
 background: white;
 border: 1px solid #e5e7eb;
 border-radius: 16px;
 padding: 24px;
 display: flex;
 gap: 20px;
 align-items: flex-start;
 transition: all 0.2s;
}

.principle-card:hover {
 border-color: #722F37;
 box-shadow: 0 8px 24px rgba(114, 47, 55, 0.1);
}

.principle-number {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #722F37, #722F37);
 color: white;
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-weight: 800;
 font-size: 18px;
 flex-shrink: 0;
}

.principle-content {
 flex: 1;
}

.principle-title {
 font-size: 18px;
 font-weight: 700;
 color: #1f2937;
 margin-bottom: 8px;
}

.principle-text {
 font-size: 15px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* SYSTEMS BOX */
.systems-box {
 background: #f8fafc;
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
 border: 1px solid #e2e8f0;
}

.systems-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
 gap: 16px;
 margin-top: 24px;
}

.system-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid #e5e7eb;
}

.system-item h4 {
 color: #722F37;
 font-size: 16px;
 margin-bottom: 8px;
}

.system-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.6;
}

/* NUTRIENT DENSITY BOX */
.nutrient-box {
 border-radius: 20px;
 padding: 32px;
 margin: 40px 0;
}

.nutrient-box.positive {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
}

.nutrient-box.positive h3 {
 color: #166534;
 margin-top: 0;
}

.nutrient-box.negative {
 background: linear-gradient(135deg, #fef2f2, #fee2e2);
 border: 1px solid #fecaca;
}

.nutrient-box.negative h3 {
 color: #991b1b;
 margin-top: 0;
}

.nutrient-grid {
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 16px;
 margin-top: 20px;
}

.nutrient-item {
 background: white;
 padding: 20px;
 border-radius: 12px;
 border: 1px solid rgba(134, 239, 172, 0.5);
}

.nutrient-item h4 {
 color: #16a34a;
 font-size: 15px;
 margin-bottom: 8px;
}

.nutrient-item p {
 font-size: 14px;
 color: #4b5563;
 margin: 0;
 line-height: 1.5;
}

/* ALERT BOXES */
.alert-box {
 padding: 24px;
 border-radius: 16px;
 margin: 32px 0;
 border-left: 4px solid;
}

.alert-box .alert-label {
 font-weight: 700;
 text-transform: uppercase;
 font-size: 11px;
 letter-spacing: 1px;
 margin-bottom: 8px;
 display: block;
}

.alert-box p {
 margin: 0;
 font-size: 15px;
}

.alert-box.warning,
.alert-box.gold {
 background: #fffbeb;
 border-color: #f59e0b;
}

.alert-box.warning .alert-label,
.alert-box.gold .alert-label {
 color: #92400e;
}

.alert-box.success {
 background: #f0fdf4;
 border-color: #22c55e;
}

.alert-box.success .alert-label {
 color: #166534;
}

.alert-box.reflect,
.alert-box.info {
 background: #faf5ff;
 border-color: #a855f7;
}

.alert-box.reflect .alert-label,
.alert-box.info .alert-label {
 color: #7e22ce;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip::before {
 content: 'üí°';
 position: absolute;
 top: -12px;
 left: 24px;
 background: white;
 padding: 4px 8px;
 border-radius: 8px;
 font-size: 20px;
 box-shadow: 0 2px 8px rgba(0,0,0,0.08);
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

.coach-tip p {
 color: #713f12;
 font-size: 15px;
 margin: 0;
 line-height: 1.7;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-icon {
 width: 44px;
 height: 44px;
 background: linear-gradient(135deg, #0ea5e9, #0284c7);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 22px;
 flex-shrink: 0;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

.module-connection .connection-text strong {
 color: #075985;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: linear-gradient(135deg, #faf5ff, #f3e8ff);
 border: 1px solid #e9d5ff;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.question-item {
 background: white;
 padding: 24px;
 border-radius: 12px;
 margin-bottom: 16px;
 border: 1px solid #e9d5ff;
}

.question-item:last-child {
 margin-bottom: 0;
}

.question-header {
 display: flex;
 align-items: flex-start;
 gap: 12px;
}

.question-number {
 background: #a855f7;
 color: white;
 width: 28px;
 height: 28px;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 14px;
 font-weight: 700;
 flex-shrink: 0;
}

.question-text {
 font-weight: 600;
 color: #4b5563;
 font-size: 15px;
 margin: 0;
 flex: 1;
}

.reveal-btn {
 background: white;
 border: 2px solid #d8b4fe;
 color: #7e22ce;
 padding: 10px 20px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 cursor: pointer;
 transition: all 0.2s;
 margin-top: 12px;
}

.reveal-btn:hover {
 background: #7e22ce;
 color: white;
 border-color: #7e22ce;
}

.answer-text {
 display: none;
 margin-top: 16px;
 padding-top: 16px;
 border-top: 1px solid #e9d5ff;
 color: #4b5563;
 font-size: 15px;
 line-height: 1.6;
}

.answer-text.show {
 display: block;
 animation: fadeIn 0.3s ease;
}

@keyframes fadeIn {
 from {
 opacity: 0;
 transform: translateY(-8px);
 }
 to {
 opacity: 1;
 transform: translateY(0);
 }
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: linear-gradient(135deg, #f0fdf4, #dcfce7);
 border: 1px solid #86efac;
 border-radius: 20px;
 padding: 32px;
 margin: 48px 0;
}

.takeaways-box .box-label {
 color: #166534;
}

.takeaways-box ul {
 list-style: none;
 padding: 0;
 margin: 0;
}

.takeaways-box li {
 padding: 12px 0 12px 32px;
 position: relative;
 font-size: 16px;
 color: #166534;
 border-bottom: 1px solid rgba(34, 197, 94, 0.2);
}

.takeaways-box li:last-child {
 border-bottom: none;
}

.takeaways-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #22c55e;
 font-weight: 700;
 font-size: 16px;
}

/* REFERENCES - Premium Academic Style */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
 display: flex;
 align-items: center;
 gap: 8px;
}

.references-box .box-label::before {
 content: 'üìö';
}

.references-box ol {
 list-style: none;
 padding: 0;
 margin: 0;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 line-height: 1.7;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li:last-child {
 margin-bottom: 0;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

.references-box li em {
 color: #722F37;
 font-weight: 500;
}

/* Data Table CSS (Mandatory) */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}
.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}
.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}
.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* RESPONSIVE */
@media (max-width: 768px) {
 .lesson-wrapper {
 padding: 24px 16px 60px;
 }

 .module-header-card {
 padding: 32px 24px;
 border-radius: 20px;
 }

 .lesson-title {
 font-size: 28px;
 }

 .comparison-grid {
 grid-template-columns: 1fr;
 }

 .systems-grid {
 grid-template-columns: 1fr;
 }

 .nutrient-grid {
 grid-template-columns: 1fr;
 }

 .toc-list {
 grid-template-columns: 1fr;
 }

 .asi-credential-strip {
 flex-direction: column;
 text-align: center;
 }

 .module-connection {
 flex-direction: column;
 text-align: center;
 }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases - Lesson 4 of 8</span>
 <h1 class="lesson-title">Advanced Renal and Hepatic Disease Nutrition</h1>
 <div class="lesson-meta">
 <span class="meta-badge"><span class="icon">‚è±Ô∏è</span> 15 min read</span>
 <span class="meta-badge"><span class="icon">üß†</span> Advanced Application</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">üéì</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute</div>
 <div class="title">Certified Dog Nutrition Specialist‚Ñ¢ Verified</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#renal-protein"><span class="section-num">01</span>Protein in Advanced CKD</a></li>
 <li><a href="#renal-electrolytes"><span class="section-num">02</span>Managing Renal Complications</a></li>
 <li><a href="#hepatic-encephalopathy"><span class="section-num">03</span>Diet for Hepatic Encephalopathy</a></li>
 <li><a href="#hepatic-ascites"><span class="section-num">04</span>Ascites & Portal Hypertension</a></li>
 <li><a href="#hepatic-micronutrients"><span class="section-num">05</span>Nutrient Deficiencies & Toxicities</a></li>
 <li><a href="#palatability"><span class="section-num">06</span>Balancing Palatability & Compliance</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>Building on our discussions in previous lessons of Module 28, where we tackled <strong class="highlight">acute nutritional emergencies</strong>, <strong class="highlight">malnutrition</strong>, and <strong class="highlight">refractory GI diseases</strong>, this lesson elevates your expertise to the most critical and delicate areas of canine nutrition: advanced renal and hepatic diseases. We move beyond foundational support to highly specific, life-extending dietary strategies for dogs facing end-stage organ failure.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Future CDNS!</h3>
 <p>In this advanced lesson, we delve into the intricate nutritional management of dogs with end-stage renal and hepatic diseases. These complex cases require a profound understanding of metabolic pathways, precise nutrient manipulation, and an empathetic approach to client education. As a Certified Dog Nutrition Specialist, mastering these interventions will empower you to significantly improve the quality of life for these critically ill pets and provide invaluable support to their devoted owners. This is where your expertise truly makes a life-changing difference, embodying the <span class="highlight">V.I.T.A.L. Framework‚Ñ¢</span> by addressing specific, severe needs.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Evaluate the nuances of protein restriction, quality, and quantity for managing advanced Chronic Kidney Disease (CKD) and uremic crises.</li>
 <li>Formulate dietary strategies to mitigate hyperphosphatemia, hyperkalemia, and metabolic acidosis in end-stage renal failure.</li>
 <li>Design nutritional interventions for dogs with hepatic encephalopathy, ascites, and portal hypertension in advanced liver disease.</li>
 <li>Identify and address specific micronutrient deficiencies (e.g., B vitamins, zinc) and toxicities (e.g., copper) prevalent in severe hepatic conditions.</li>
 <li>Develop practical approaches to balance dietary palatability with strict nutritional compliance in dogs suffering from advanced organ failure.</li>
 <li>Communicate complex dietary plans and their rationale effectively to owners, fostering adherence and hope.</li>
 </ul>
 </div>

 <!-- Case Study 1: Advanced CKD -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üê∂</div>
 <div>
 <p class="title">Case Study: Luna's Renal Journey</p>
 <p class="subtitle">Navigating End-Stage Kidney Disease</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <h4>Patient Profile: Luna</h4>
 <p><strong>Breed:</strong> Golden Retriever, female spayed</p>
 <p><strong>Age:</strong> 12 years old</p>
 <p><strong>Presenting Symptoms:</strong> Diagnosed with IRIS Stage 4 Chronic Kidney Disease (CKD) with elevated creatinine (4.5 mg/dL), BUN (90 mg/dL), and phosphorus (7.2 mg/dL). Owner, Sarah (55, former teacher), noted progressive lethargy, decreased appetite, intermittent vomiting, and weight loss (5% over 2 months). Luna had a history of Stage 2 CKD for 2 years, managed with a commercial renal diet, but her condition recently declined.</p>
 <p><strong>Challenges:</strong> Luna was refusing her prescription renal diet, leading to further weight loss and worsening uremic symptoms. Sarah was distressed, feeling helpless as her beloved companion faded.</p>
 </div>
 <p>This scenario highlights the critical need for advanced nutritional strategies when standard interventions fail. For Luna, the initial renal diet was no longer sufficient, and her aversion to it was exacerbating her crisis. We'll explore how to address these specific challenges throughout this lesson, focusing on extending both life and quality of life.</p>
 </div>
 </div>

 <h2><span id="renal-protein">1. Nuances of Protein Restriction and Quality in Advanced CKD</span></h2>
 <p>For dogs with advanced <span class="highlight">Chronic Kidney Disease (CKD)</span>, particularly IRIS Stages 3 and 4, managing protein intake is a delicate balance. The goal is to reduce the workload on the kidneys by minimizing nitrogenous waste products (which contribute to uremia) without causing protein-calorie malnutrition or muscle wasting. This is a shift from earlier stages where moderate restriction might suffice.</p>

 <h3>Protein Quantity and Quality</h3>
 <ul>
 <li><strong>Severe Restriction (Not Always the Answer):</strong> While protein restriction is crucial, overly severe restriction can lead to <span class="highlight">negative nitrogen balance</span>, resulting in muscle catabolism and worsening cachexia. Studies suggest that protein restriction in early CKD may not significantly slow progression, but it becomes vital in advanced stages to manage clinical signs of uremia (Polzin et al., 2010).</li>
 <li><strong>High Biological Value (HBV) Protein:</strong> The type of protein is paramount. We prioritize <span class="highlight">High Biological Value (HBV) proteins</span>, which have an amino acid profile closely matching the dog's requirements, allowing for maximal utilization and minimal waste product generation.</li>
 <li><strong>Recommended Levels:</strong> For IRIS Stage 3-4 CKD, protein intake typically ranges from <span class="highlight">0.8-1.2 g/kg body weight per day</span> (Michel, 2012). This is a significant reduction from the 2.0-2.5 g/kg/day often recommended for healthy adults but is carefully calibrated to meet essential amino acid needs.</li>
 </ul>

 <div class="coach-tip">
 <div class="coach-tip-header">
 <span class="coach-icon">üí°</span>
 <span class="coach-label">Coach's Tip</span>
 </div>
 <div class="coach-tip-content">
 <p><strong>Educating Owners on Protein:</strong> Many owners struggle with the concept of reducing protein for their carnivores. Explain that it's about <strong class="highlight">"less quantity, higher quality"</strong>. Use an analogy: "Think of it like a car with a broken exhaust. We're not taking away fuel, but making sure the fuel burns cleanly, producing less toxic smoke. High-quality protein means less 'smoke' for Luna's kidneys to filter."</p>
 </div>
 </div>

 <h3>Managing Uremic Crises</h3>
 <p>A <span class="highlight">uremic crisis</span> is a medical emergency characterized by severe clinical signs (anorexia, vomiting, extreme lethargy) due to high levels of uremic toxins. Nutritional goals include:</p>
 <ul>
 <li><strong>Immediate Symptomatic Relief:</strong> While medical stabilization is primary, nutritional support focuses on maintaining hydration and providing readily digestible, low-protein energy sources.</li>
 <li><strong>Transition to Renal Diet:</strong> Once stabilized, a gradual transition to an appropriate renal diet is critical. Palatability becomes a major challenge, often requiring multiple food trials, warming food, or adding small amounts of flavor enhancers (e.g., low-sodium broth).</li>
 <li><strong>Monitoring:</strong> Close monitoring of BUN, creatinine, phosphorus, and potassium levels is essential to adjust the diet as needed.</li>
 </ul>

 <h2><span id="renal-electrolytes">2. Strategies for Managing Hyperphosphatemia, Hyperkalemia, and Metabolic Acidosis</span></h2>
 <p>Beyond protein, advanced CKD often presents with serious electrolyte and acid-base imbalances that require specific dietary interventions.</p>

 <h3>Hyperphosphatemia</h3>
 <p>Elevated serum phosphorus (<span class="highlight">hyperphosphatemia</span>) is a hallmark of advanced CKD and contributes to renal secondary hyperparathyroidism, exacerbating kidney damage and leading to severe bone disease. Dietary management includes:</p>
 <ul>
 <li><strong>Phosphorus Restriction:</strong> This is achieved by limiting high-phosphorus foods (e.g., organ meats, bone, certain dairy products). Commercial renal diets are formulated to be phosphorus-restricted.</li>
 <li><strong>Phosphate Binders:</strong> For dogs with persistent hyperphosphatemia despite dietary restriction (serum phosphorus >4.5 mg/dL in IRIS Stage 3, or >5.0 mg/dL in IRIS Stage 4), oral phosphate binders (e.g., aluminum hydroxide, calcium acetate) administered with meals are often necessary (Elliott et al., 2007).</li>
 <li><strong>Fresh Food Considerations:</strong> When formulating fresh food diets, selecting phosphorus-reduced ingredients (e.g., egg whites, specific lean meats with careful portioning, low-phosphorus vegetables) and ensuring proper calcium-to-phosphorus ratios (ideally 1.2:1 to 1.5:1) is vital.</li>
 </ul>

 <h3>Hyperkalemia</h3>
 <p>High serum potassium (<span class="highlight">hyperkalemia</span>) can be life-threatening, causing cardiac arrhythmias. While less common in dogs with CKD than in cats, it can occur, particularly in conjunction with oliguric acute kidney injury or certain medications.</p>
 <ul>
 <li><strong>Dietary Potassium Restriction:</strong> Avoid foods naturally high in potassium (e.g., bananas, potatoes, certain leafy greens, many fruits). Commercial renal diets are typically formulated with controlled potassium levels.</li>
 <li><strong>Monitoring:</strong> Regular electrolyte monitoring is critical.</li>
 </ul>

 <h3>Metabolic Acidosis</h3>
 <p>As kidney function declines, the kidneys lose their ability to excrete acid, leading to <span class="highlight">metabolic acidosis</span>. This can cause muscle wasting, lethargy, and contribute to progressive renal damage.</p>
 <ul>
 <li><strong>Alkalinizing Diets:</strong> Dietary strategies focus on providing bicarbonate precursors. Commercial renal diets often contain alkalinizing agents (e.g., potassium citrate).</li>
 <li><strong>Avoid Acidifying Foods:</strong> Foods that produce an acidic ash (e.g., very high protein animal products without sufficient alkalinizing components) should be limited.</li>
 </ul>

 <div class="data-table-container">
 <table class="data-table">
 <thead>
 <tr>
 <th>Imbalance</th>
 <th>Dietary Strategy</th>
 <th>Key Considerations</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Hyperphosphatemia</strong></td>
 <td>Phosphorus restriction (0.2-0.5% dry matter), use of phosphate binders.</td>
 <td>HBV proteins, careful Ca:P ratio (1.2:1-1.5:1). Monitor serum P regularly.</td>
 </tr>
 <tr>
 <td><strong>Hyperkalemia</strong></td>
 <td>Potassium restriction (0.3-0.6% dry matter), avoid high-K foods.</td>
 <td>Less common in CKD dogs; closely monitor with oliguria or certain medications.</td>
 </tr>
 <tr>
 <td><strong>Metabolic Acidosis</strong></td>
 <td>Alkalinizing agents (e.g., potassium citrate) in diet.</td>
 <td>Ensure diet provides adequate bicarbonate precursors. Avoid acidifying foods.</td>
 </tr>
 <tr>
 <td><strong>Uremia (Protein Waste)</strong></td>
 <td>HBV protein restriction (0.8-1.2 g/kg BW/day).</td>
 <td>Prevent muscle wasting; monitor BUN/creatinine, clinical signs.</td>
 </tr>
 </tbody>
 </table>
 </div>

 <h2><span id="hepatic-encephalopathy">3. Dietary Interventions for Hepatic Encephalopathy</span></h2>
 <p><span class="highlight">Hepatic encephalopathy (HE)</span> is a severe neurological syndrome that occurs in dogs with advanced liver disease when the liver can no longer detoxify ammonia and other toxins, which then accumulate in the bloodstream and affect brain function. Dietary management is cornerstone for controlling HE.</p>

 <h3>Protein in Hepatic Encephalopathy</h3>
 <p>Historically, severe protein restriction was the primary treatment for HE. However, current understanding emphasizes a more nuanced approach:</p>
 <ul>
 <li><strong>Moderate Protein Restriction:</strong> Complete protein restriction can lead to malnutrition and muscle catabolism, which paradoxically increases ammonia production from muscle breakdown. Moderate restriction (1.5-2.0 g/kg BW/day) of HBV protein is often more appropriate (Center, 2013).</li>
 <li><strong>Type of Protein:</strong>
 <ul>
 <li><strong>Plant-based Proteins:</strong> Soy protein, in particular, has been shown to be beneficial due to its lower content of aromatic amino acids (AAAs) and higher content of branched-chain amino acids (BCAAs), which compete with AAAs for transport across the blood-brain barrier.</li>
 <li><strong>Dairy Proteins:</strong> Casein and cottage cheese are also well-tolerated and can be good HBV sources.</li>
 <li><strong>Avoid Red Meat:</strong> Red meats are often higher in AAAs and can exacerbate HE symptoms.</li>
 </ul>
 </li>
 <li><strong>Small, Frequent Meals:</strong> This helps reduce the postprandial ammonia surge.</li>
 </ul>

 <h3>Fiber and Gut Health</h3>
 <p>Dietary fiber plays a crucial role in managing HE:</p>
 <ul>
 <li><strong>Soluble Fiber:</strong> Fermentable fibers (e.g., psyllium, beet pulp, fructooligosaccharides) promote the growth of beneficial gut bacteria that produce short-chain fatty acids. This lowers colonic pH, which traps ammonia in its ionized form (NH4+), preventing its absorption into the bloodstream (Webster et al., 2002).</li>
 <li><strong>Lactulose:</strong> Often used in conjunction with dietary management, lactulose is a synthetic disaccharide that is fermented by colonic bacteria, producing lactic acid and other organic acids, further acidifying the colon and reducing ammonia absorption.</li>
 </ul>

 <div class="coach-tip">
 <div class="coach-tip-header">
 <span class="coach-icon">üí°</span>
 <span class="coach-label">Coach's Tip</span>
 </div>
 <div class="coach-tip-content">
 <p><strong>Explaining HE to Owners:</strong> Hepatic encephalopathy can be frightening for owners. Explain it simply: "Luna's liver can't clean her blood properly, so toxins build up and make her brain foggy. Our special diet helps her gut trap those toxins and reduces the liver's workload, helping her feel more like herself." This empowers them to understand the diet's critical role.</p>
 </div>
 </div>

 <h2><span id="hepatic-ascites">4. Managing Ascites and Portal Hypertension in Advanced Liver Disease</span></h2>
 <p><span class="highlight">Ascites</span> (fluid accumulation in the abdomen) and <span class="highlight">portal hypertension</span> (increased blood pressure in the portal vein system) are common complications of advanced liver disease, particularly cirrhosis. Nutritional management focuses on fluid and sodium restriction.</p>

 <h3>Sodium Restriction</h3>
 <ul>
 <li><strong>Severe Restriction:</strong> For dogs with ascites, severe sodium restriction is critical to reduce fluid retention. This means avoiding high-sodium foods (processed treats, table scraps, many commercial kibbles not formulated for liver disease).</li>
 <li><strong>Commercial Liver Diets:</strong> Prescription liver diets are typically sodium-restricted (often <span class="highlight">0.1-0.2% dry matter</span>).</li>
 <li><strong>Homemade Diets:</strong> When formulating a fresh food diet, careful attention must be paid to sodium content of all ingredients, including supplements.</li>
 </ul>

 <h3>Fluid Management</h3>
 <ul>
 <li><strong>Diuretics:</strong> Diuretic medications are often necessary to manage ascites, but dietary sodium restriction enhances their effectiveness.</li>
 <li><strong>Monitoring:</strong> Regular weighing and abdominal girth measurements help monitor fluid status.</li>
 </ul>

 <h2><span id="hepatic-micronutrients">5. Addressing Specific Nutrient Deficiencies and Toxicities in Severe Hepatic Conditions</span></h2>
 <p>The liver plays a central role in nutrient metabolism, storage, and detoxification. Dysfunction can lead to a myriad of micronutrient imbalances.</p>

 <h3>Vitamin Deficiencies</h3>
 <ul>
 <li><strong>B Vitamins:</strong> The liver is crucial for B vitamin activation and storage. Dogs with liver disease often have deficiencies in <span class="highlight">thiamine (B1), riboflavin (B2), pyridoxine (B6), cobalamin (B12)</span>, and <span class="highlight">folate</span> due to decreased absorption, increased demand, or impaired storage. Supplementation is often necessary.</li>
 <li><strong>Fat-Soluble Vitamins (A, D, E, K):</strong> Bile acid production and flow are often impaired in liver disease, leading to malabsorption of fat-soluble vitamins. Supplementation, sometimes with water-miscible forms, may be required, but careful monitoring of Vitamin A and D levels is important due to potential for toxicity.</li>
 </ul>

 <h3>Mineral Imbalances</h3>
 <ul>
 <li><strong>Zinc:</strong> Zinc is a cofactor for numerous hepatic enzymes and plays a role in ammonia detoxification. Dogs with liver disease, especially those with HE, often have <span class="highlight">zinc deficiency</span>. Supplementation (e.g., zinc gluconate or picolinate) may be beneficial, but careful dosing is needed to avoid copper-zinc antagonism if copper is also a concern.</li>
 <li><strong>Copper:</strong> Certain breeds (e.g., Bedlington Terriers, West Highland White Terriers, Labrador Retrievers, Dalmatians) are predisposed to <span class="highlight">copper storage disease</span>, where copper accumulates in the liver, leading to oxidative damage and cirrhosis. For these breeds, and any dog with suspected copper hepatopathy, a <span class="highlight">severely copper-restricted diet</span> is essential (often <span class="highlight">less than 5 mg/kg dry matter</span>).</li>
 <li><strong>Iron:</strong> While iron deficiency can occur with chronic GI bleeding, iron overload is also a concern in some liver diseases. Iron levels should be monitored.</li>
 </ul>

 <div class="alert-box warning">
 <p class="alert-label">Critical Warning</p>
 <p>Micronutrient supplementation in liver disease is complex. <strong class="highlight">Excessive supplementation of fat-soluble vitamins (A, D, E, K) or certain minerals (e.g., iron, copper) can be toxic</strong> or exacerbate liver damage. Always work closely with the veterinary team and monitor blood levels when recommending supplementation.</p>
 </div>

 <h2><span id="palatability">6. Balancing Palatability and Strict Dietary Compliance</span></h2>
 <p>This is often the greatest challenge in managing advanced organ disease. Dogs with CKD or liver disease frequently experience anorexia, nausea, and taste aversion, making strict dietary compliance incredibly difficult.</p>

 <ul>
 <li><strong>Anorexia and Nausea:</strong> Uremic toxins (CKD) and hepatic toxins (liver disease) directly cause nausea and reduced appetite. Anti-emetic medications (e.g., maropitant) can be very helpful.</li>
 <li><strong>Food Aversion:</strong> Dogs can develop a strong aversion to specific foods if they associate them with feeling unwell. This means that even a perfectly formulated diet is useless if the dog refuses to eat it.</li>
 <li><strong>Strategies for Enhancing Palatability:</strong>
 <ul>
 <li><strong>Variety of Textures and Temperatures:</strong> Offer canned, semi-moist, or warmed foods.</li>
 <li><strong>Flavor Enhancers:</strong> Small amounts of low-sodium chicken or beef broth, fish oil (omega-3s are beneficial for both renal and hepatic disease), or specific appetite stimulants (under veterinary guidance).</li>
 <li><strong>Multiple Small Meals:</strong> Instead of two large meals, offer 4-6 smaller meals throughout the day.</li>
 <li><strong>Hand-Feeding:</strong> Gentle hand-feeding can encourage intake.</li>
 <li><strong>Consider Novel Proteins:</strong> For some, a novel protein source (e.g., duck, venison) may be more appealing, but must fit within protein quality/quantity restrictions.</li>
 </ul>
 </li>
 <li><strong>Client Support:</strong> This is emotionally exhausting for owners. As a CDNS, your role is not just to provide the diet, but to provide <span class="highlight">compassionate coaching and unwavering support</span>. Help them understand that every bite counts, and that flexibility within the dietary guidelines is sometimes necessary for overall intake.</li>
 </ul>

 <!-- Case Study 2: Luna's Outcome -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">‚úÖ</div>
 <div>
 <p class="title">Case Study Outcome: Luna's Continued Journey</p>
 <p class="subtitle">A Holistic Approach to Renal Support</p>
 </div>
 </div>
 <div class="case-study-content">
 <div class="patient-profile">
 <h4>Outcome for Luna</h4>
 <p><strong>Intervention:</strong> Working with Luna's veterinarian, Sarah (CDNS) implemented a multi-pronged approach. First, Luna was hospitalized for IV fluid therapy and anti-emetics to stabilize her uremic crisis. Upon discharge, Sarah formulated a highly palatable, fresh-food renal diet using carefully selected, <span class="highlight">high biological value egg whites and small amounts of lean chicken</span>, balanced with low-phosphorus carbohydrates (e.g., cooked sweet potato) and a renal-specific vitamin/mineral blend. Phosphate binders were also prescribed by the vet. Sarah advised Sarah on warming the food, hand-feeding, and splitting meals into 5-6 small portions daily.</p>
 <p><strong>Results:</strong> Within two weeks, Luna's appetite significantly improved, and she gained back 3% of her body weight. Her BUN and creatinine stabilized, and her phosphorus levels dropped to 5.0 mg/dL. While still Stage 4 CKD, Luna's quality of life vastly improved. She was more alert, enjoyed short walks, and showed enthusiasm for mealtime again. Sarah felt empowered and relieved, grateful for the personalized approach.</p>
 </div>
 <p class="case-context">Luna's case demonstrates that even in advanced stages, a thoughtful, personalized nutritional plan, combined with veterinary care, can dramatically improve both clinical parameters and the dog's overall well-being. It underscores the CDNS's role in translating complex science into actionable, palatable strategies.</p>
 </div>
 </div>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">1</span>
 <p class="question-text">For a dog with IRIS Stage 4 CKD experiencing uremic symptoms, what is the primary consideration regarding dietary protein, and why?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 The primary consideration is to provide <strong class="highlight">moderately restricted, high biological value (HBV) protein</strong>. The goal is to reduce nitrogenous waste products (to alleviate uremia) while preventing protein-calorie malnutrition and muscle wasting. HBV proteins are efficiently utilized, producing less waste.
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">2</span>
 <p class="question-text">A dog with advanced liver disease develops hepatic encephalopathy. What dietary protein strategy would you recommend, and what other dietary component is crucial?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 For hepatic encephalopathy, recommend <strong class="highlight">moderate protein restriction using plant-based or dairy HBV proteins</strong> (e.g., soy, casein). Avoid red meats. Crucially, <strong class="highlight">soluble fiber</strong> (e.g., psyllium, beet pulp) is essential to promote beneficial gut bacteria, lower colonic pH, and trap ammonia, reducing its absorption.
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">3</span>
 <p class="question-text">Why is zinc supplementation often considered for dogs with severe hepatic conditions, and what is a critical mineral to monitor for toxicity in some liver diseases?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 <strong class="highlight">Zinc supplementation</strong> is considered because zinc is a cofactor for numerous hepatic enzymes and aids in ammonia detoxification; deficiencies are common in liver disease. <strong class="highlight">Copper</strong> is a critical mineral to monitor for toxicity, especially in breeds predisposed to copper storage disease, where severe dietary copper restriction is necessary.
 </div>
 </div>
 <div class="question-item">
 <div class="question-header">
 <span class="question-number">4</span>
 <p class="question-text">What is the biggest challenge in managing advanced organ failure nutritionally, and what are two practical strategies to overcome it?</p>
 </div>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">
 The biggest challenge is <strong class="highlight">anorexia and maintaining palatability and compliance</strong>. Two practical strategies include: 1) Offering a variety of textures and temperatures (e.g., warmed canned food, small amounts of low-sodium broth), and 2) Implementing multiple small meals throughout the day, possibly combined with hand-feeding, to encourage consistent intake and reduce post-meal nausea.
 </div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Advanced CKD requires <strong class="highlight">moderately restricted, high biological value protein</strong> to manage uremia while preventing muscle catabolism.</li>
 <li>Electrolyte imbalances like <strong class="highlight">hyperphosphatemia, hyperkalemia, and metabolic acidosis</strong> in CKD demand precise dietary phosphorus, potassium, and alkalinizing strategies.</li>
 <li>Hepatic encephalopathy benefits from <strong class="highlight">moderate, carefully selected protein sources</strong> (plant-based, dairy) and liberal <strong class="highlight">soluble fiber</strong> to manage ammonia.</li>
 <li>Ascites and portal hypertension in liver disease necessitate <strong class="highlight">severe sodium restriction</strong> to control fluid retention.</li>
 <li>Micronutrient management in liver disease is complex, focusing on addressing <strong class="highlight">B vitamin and zinc deficiencies</strong> while strictly monitoring for <strong class="highlight">copper and iron toxicities</strong>.</li>
 <li><strong class="highlight">Palatability and client compliance</strong> are paramount; employ creative feeding strategies and provide empathetic support to ensure adequate nutritional intake.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Polzin, D. J., et al. (2010). "Evidence-based recommendations for the management of canine chronic kidney disease." <em>Journal of Veterinary Internal Medicine</em>, 24(2), 291-305.</li>
 <li>Michel, K. E. (2012). "Nutritional management of chronic kidney disease in dogs and cats." <em>Veterinary Clinics of North America: Small Animal Practice</em>, 42(4), 687-698.</li>
 <li>Elliott, J., et al. (2007). "Phosphorus restriction in the management of feline chronic kidney disease." <em>Journal of Veterinary Internal Medicine</em>, 21(6), 1183-1189.</li>
 <li>Center, S. A. (2013). "Nutritional management of liver disease." <em>Veterinary Clinics of North America: Small Animal Practice</em>, 43(6), 1335-1350.</li>
 <li>Webster, C. R., et al. (2002). "Clinical signs and laboratory abnormalities in dogs with hepatic encephalopathy: 39 cases (1990-1996)." <em>Journal of the American Veterinary Medical Association</em>, 221(1), 107-112.</li>
 <li>Freeman, L. M., et al. (2006). "Nutritional management of canine and feline chronic liver disease." <em>Journal of Veterinary Internal Medicine</em>, 20(2), 241-246.</li>
 <li>Roudebush, P., et al. (2012). "An evidence-based review of the nutritional management of canine chronic kidney disease." <em>Journal of Small Animal Practice</em>, 53(12), 675-681.</li>
 <li>Watson, P. (2011). "Chronic hepatitis in dogs: a review of current concepts of pathogenesis, diagnosis, and treatment." <em>Journal of Small Animal Practice</em>, 52(1), 1-13.</li>
 </ol>
 </div>

</div>

<script>
 document.querySelectorAll('.reveal-btn, .reveal-button').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && (answer.classList.contains('answer-text') || answer.classList.contains('reveal-answer'))) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>